Biocryst Pharmaceuticals (BCRX) Property, Plant & Equipment (Net) (2010 - 2026)
Biocryst Pharmaceuticals (BCRX) Property, Plant & Equipment (Net) (2010 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.78 Bn | 87.91 Bn | - | 37.35 Bn |
| 2 | Teva Pharmaceutical Industries | 36.02 Bn | 32.28 Bn | 1.97 Bn | 4.00 Bn |
| 3 | Zoetis | 32.60 Bn | 30.66 Bn | 1.62 Bn | 3.72 Bn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | 13.52 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.94 Bn | 648.10 Mn | 1.84 Bn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | 49,000.00 |
| 7 | Viatris | 20.35 Bn | 18.54 Bn | 1.16 Bn | 2.53 Bn |
| 8 | Neurocrine Biosciences | 17.82 Bn | 16.50 Bn | 800.70 Mn | 90.90 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | 1.40 Bn |
| 10 | Biocryst Pharmaceuticals | 2.37 Bn | 2.30 Bn | 151.04 Mn | 9.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.37 Mn |
| Mar 31, 2026 | 9.37 Mn |
| Dec 31, 2025 | 8.78 Mn |
| Dec 31, 2025 | 8.78 Mn |
| Sep 30, 2025 | 8.40 Mn |
| Sep 30, 2025 | 8.40 Mn |
| Jun 30, 2025 | 8.46 Mn |
| Jun 30, 2025 | 8.46 Mn |
| Mar 31, 2025 | 7.59 Mn |
| Mar 31, 2025 | 7.59 Mn |
| Dec 31, 2024 | 7.78 Mn |
| Dec 31, 2024 | 7.78 Mn |
| Sep 30, 2024 | 7.42 Mn |
| Sep 30, 2024 | 7.42 Mn |
| Jun 30, 2024 | 7.66 Mn |
| Jun 30, 2024 | 7.66 Mn |
| Mar 31, 2024 | 7.83 Mn |
| Mar 31, 2024 | 7.83 Mn |
| Dec 31, 2023 | 7.91 Mn |
| Dec 31, 2023 | 7.91 Mn |